News Alert

GOP Retains Control of U.S. House to Put Republicans in Charge of Congress, White House

Republicans reportedly clinched control of the U.S. House of Representatives, though the leader of a committee with jurisdiction over 340B has not yet been decided.
Republicans reportedly clinched control of the U.S. House of Representatives on Wednesday, officially winning key races that put them over [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Breaking News

Senate GOP Selects Thune, a 340B Champion, as Next Majority Leader Despite Pushback from Trump Allies

Senate Republicans on Wednesday selected U.S. Sen. John Thune (R-S.D.) as their next majority leader.
One week after clinching control of the U.S. Senate, GOP senators elected U.S. Sen. John Thune (R-S.D.), the chamber’s second-ranking [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

GOP Returns to Power: How the 2024 Election Outcomes Could Affect the 340B Program

Former President Donald Trump's (R) victory in Tuesday’s presidential election could have significant implications for the 340B program.
Former President Donald Trump’s victory over Democratic Vice President Kamala Harris in Tuesday’s presidential election capped a series of high-profile [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

November 5 is Finally Here: How the 2024 Elections Could Affect the 340B Program

Voters will cast ballots in Tuesday's presidential contest between Vice President Kamala Harris (D) and former President Donald Trump (R).
When voters across the U.S. cast their ballots in Tuesday’s elections, they will not just be deciding who will control [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Pfizer CEO Calls 340B ‘One of the Biggest Issues’ During Earnings Call Touting $17.1B in Quarterly Revenue

Pfizer CEO Albert Bourla told investors that "340B reform is something that myself and the entire pharma [industry] is setting as a priority."
Pfizer’s top executive told investors this week that the 340B program “is one of the biggest issues,” during an earnings [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Former Presidential Candidate Howard Dean Calls for More 340B Transparency, Declines to Discuss Op-ed, Alleged Drug Industry Ties

Howard Dean urged federal lawmakers in an Oct. 25 RealClearHealth op-ed to pay attention to the 340B program.
A high-profile former Vermont governor with reported drug industry ties took aim at hospitals’ use of 340B savings, calling for [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Group That Does Not Disclose Its Funding Releases White Paper Calling for 340B Reforms, Advocates Slam Report

The Health Equity Collaborative called for 340B program overhauls in a new white paper.
An organization that describes itself as being “comprised of dozens of national, public health, patient advocacy and multicultural organizations,” but [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

340B Lobbying Activity Did Not Slow Down in Q3, Federal Filings Suggest

340B Working Table
More than 360 firms reported lobbying on the 340B program between July 1 and Sept. 30.
The 340B drug discount program continued to be a hot topic for lobbyists in the third quarter of 2024, keeping [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Dark Money Poured Nearly $4M into Super PAC Opposing State 340B Contract Pharmacy Access Bills

Stand for US PAC received $3.8 million in contributions over the last three months from a conservative dark money group.
A political action committee (PAC) that funded efforts opposing state 340B contract pharmacy access bills through misleading claims linking the [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Arkansas Begins Enforcement Against AstraZeneca for Allegedly Violating Contract Pharmacy Access Law

The Arkansas Insurance Department held a preliminary hearing with attorneys for AstraZeneca on Oct. 1.
Arkansas officials initiated enforcement proceedings earlier this week against AstraZeneca for allegedly violating a state law that prohibits drugmaker 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live